EUVIMEDEUVIMED entdecken
Crossref

Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro

Jinsoo Kim, Qinghong Han, Shukuan Li, Byung Mo Kang, Kohei Mizuta, Yohei Asano, Yuta Miyashi, Michael Bouvet, Robert M Hoffman

Anticancer Research · 2026

DOI: 10.21873/anticanres.17980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Jinsoo Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Methionine Adenosyltransferase, Carbon-Sulfur Lyases, Antineoplastic Agents, Enzyme Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methionine AdenosyltransferaseCarbon-Sulfur LyasesAntineoplastic AgentsEnzyme InhibitorsHumansRecombinant ProteinsHCT116 CellsCell SurvivalDrug SynergismCell Line, Tumor

Stichwörter der Autor:innen

AG-270HCT116 colon cancer cellsHoffman effectHs-27 normal fibroblastsMAT2Acombinationmethionine addictionrecombinant methioninasesynergy

Substanzen

Methionine AdenosyltransferaseL-methionine gamma-lyaseCarbon-Sulfur LyasesRecombinant ProteinsMAT2A protein, humanAntineoplastic AgentsEnzyme Inhibitors

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Kim, J., Han, Q., Li, S., Kang, B. M., Mizuta, K., Asano, Y., Miyashi, Y., Bouvet, M., & Hoffman, R. M. (2026). Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro. Anticancer Research. https://doi.org/10.21873/anticanres.17980

Vancouver

Kim J, Han Q, Li S, Kang BM, Mizuta K, Asano Y, et al. Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro. Anticancer Research. 2026. doi:10.21873/anticanres.17980

BibTeX
@article{Kim2026,
  author = {Kim, Jinsoo and Han, Qinghong and Li, Shukuan and Kang, Byung Mo and Mizuta, Kohei and Asano, Yohei and Miyashi, Yuta and Bouvet, Michael and Hoffman, Robert M},
  title = {Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17980}
}
Kostenlos starten →